Arcellx (ACLX) Return on Sales (2023 - 2025)
Arcellx's quarterly Return on Sales came in at 0.35% in Q4 2025, down 32.0% year-on-year from 0.52% in Q4 2024, and down 208.63% quarter-over-quarter from 0.11% in Q3 2025.
Arcellx has reported Return on Sales for 3 years, with the latest figure at 0.35% in Q4 2025.
- For the quarter ending Q4 2025, Return on Sales fell 32.0% year-over-year to 0.35%; the trailing twelve-month figure through Dec 2025 stood at 0.1% (down 9.0% YoY), and the FY2025 full-year result was 0.1%, down 9.0% from the prior year.
- Return on Sales for Q4 2025 stood at 0.35%, down from 0.11% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q4 2023, with the low at 0.35% in Q4 2025.
- Average Return on Sales over 3 years is 0.06%, with a median of 0.02% recorded in 2023.
- Year-over-year, Return on Sales climbed 2 bps in 2024 and sank 32 bps in 2025.
- Tracing ACLX's Return on Sales over 3 years: stood at 0.0% in 2023, then plunged by 1081 bps to 0.03% in 2024, then tumbled by 1039 bps to 0.35% in 2025.
- The last three Return on Sales figures came in at 0.35% (Q4 2025), 0.11% (Q3 2025), and 0.07% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -0.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.35% |
| Sep 30, 2025 | -0.11% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |